0001209191-22-015921.txt : 20220303
0001209191-22-015921.hdr.sgml : 20220303
20220303194045
ACCESSION NUMBER: 0001209191-22-015921
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CORASH LAURENCE M
CENTRAL INDEX KEY: 0001193209
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21937
FILM NUMBER: 22711414
MAIL ADDRESS:
STREET 1: C/O CERUS CORP
STREET 2: 2411 STENWELL DRIVE
CITY: CONCORD
STATE: CA
ZIP: 94520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CERUS CORP
CENTRAL INDEX KEY: 0001020214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 680262011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
BUSINESS PHONE: 9252886000
MAIL ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
FORMER COMPANY:
FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC
DATE OF NAME CHANGE: 19960731
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-01
0
0001020214
CERUS CORP
CERS
0001193209
CORASH LAURENCE M
C/O CERUS CORPORATION
1220 CONCORD AVE SUITE 600
CONCORD
CA
94520
0
1
0
0
Chief Scientific Officer
Restricted Stock Unit
2022-03-01
4
A
0
45000
0.00
A
2072586
D
Option (Right to Buy)
5.76
2022-03-01
4
A
0
90000
A
2032-02-28
Common Stock
90000
90000
D
Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter.
Not applicable.
Laurence M. Corash by Chrystal Menard, attorney-in-fact
2022-03-03